Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Bayer CropScience has informed that in the wake of the global COVID-19 pandemic, and in compliance with the directives of Government of India/ State Governments, the Company has adopted several measures to ensure the safety and wellbeing of all its employees, including providing IT infrastructure and connectivity to enable them to work from home. Across the office and site locations, the Company has implemented heightened hygiene, health and sanitation measures and is promoting social distancing. In view of the 21-day nationwide lockdown announced by the Government of India (GOI) with effect from March 25, 2020, to control the spread of COVID-19, the Company’s operations related to manufacturing, supply chain, warehouses, and offices are disrupted (except for certain essential services). The impact of COVID-19 on the Company’s operations cannot be fully ascertained at this point.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: